Sickle Cell Disease: Anaesthesia for Cholecystectomy

At 07:30, an adult with sickle cell anaemia (haemoglobin SS [HbSS]) arrives for elective laparoscopic cholecystectomy. They feel well today, but their history includes recurrent vaso-occlusive pain episodes and a previous admission with acute chest syndrome (ACS). The operation is familiar; the transfusion decision is not.

Perioperative management hinges on the patient’s disease phenotype, baseline haemoglobin, surgical risk and transfusion history—not genotype alone. The question is not simply whether to transfuse. It is how much benefit is likely, what transfusion could cost, and how to protect the lungs after surgery.

Decide whether the patient is ready for surgery

A stable examination on the morning of surgery does not erase the history. Ask how often pain episodes occur and when the last one happened. Establish whether the patient has had ACS, stroke, priapism or a serious postoperative complication. Review baseline exercise tolerance and oxygen saturation. Ask about pulmonary hypertension, asthma, sleep-disordered breathing, renal impairment, proteinuria, avascular necrosis and chronic pain; each may change the plan.

Review current treatment, including hydroxyurea and regular transfusions, as well as baseline analgesics and opioid requirements. A careful transfusion history is essential. Ask about red-cell antibodies, delayed haemolytic transfusion reactions and hyperhaemolysis. A previous severe reaction can make a preoperative transfusion hazardous and difficult to arrange.

Compare the full blood count with the patient’s usual haemoglobin. Check renal function and electrolytes; a reticulocyte count may help if there is a clinical question about anaemia or haemolysis. Review the antibody screen and contact the transfusion laboratory early, since compatible blood may need advance planning. Record baseline oxygen saturation. Order further cardiopulmonary tests to answer a specific clinical question, such as suspected pulmonary hypertension, rather than as a reflex.

If the patient is febrile or having an active painful crisis, postpone elective surgery and involve the haematology team. Do not anaesthetise through an acute illness simply because the operating list is ready.

Make transfusion a patient-specific decision

Laparoscopic cholecystectomy is an abdominal procedure generally treated as medium risk in sickle-cell perioperative frameworks. The British Society for Haematology recommends perioperative transfusion for patients with HbSS undergoing medium-risk surgery. The American Society of Hematology conditionally suggests preoperative transfusion when general anaesthesia is expected to last more than an hour. It emphasises individualising the decision according to genotype, surgical risk, baseline haemoglobin, disease severity and previous transfusion complications.

The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) trial gives useful context. Of 67 analysed participants, 65 had HbSS and 54 were scheduled for medium-risk surgery. Clinically important complications occurred in 39% of patients who had no preoperative transfusion and 15% of those who did. Ten of the 11 serious adverse events were ACS. The results support considering transfusion for HbSS patients having low- or medium-risk surgery; they do not establish one strategy for every patient.

For patients likely to benefit, baseline haemoglobin helps determine the method. Simple transfusion can increase oxygen-carrying capacity when haemoglobin is low. The ASH approach is to aim for a preoperative haemoglobin above 9 g/dL, with a post-transfusion level no higher than 11 g/dL. It suggests simple transfusion when haemoglobin is below 9 g/dL, and consideration of red-cell exchange (RCE) when the baseline is already above about 9–10 g/dL and simple transfusion could raise viscosity excessively.

Exchange is not automatically required just because the patient has HbSS. Nor is a very low HbS fraction the routine target for every moderate-risk operation. Exchange may be considered for very high-risk surgery, such as cardiac or neurosurgery, or for a particularly severe phenotype—for example, previous stroke, recurrent ACS or a serious postoperative complication. The haematology and transfusion teams should help set the method and target, especially if the patient has alloantibodies or a serious transfusion-reaction history. Coordinate with the transfusion laboratory to select HbS-negative, ABO-, Rh- and Kell-compatible blood, with additional compatibility for known antibodies.

Imagine the patient’s baseline haemoglobin is 7.8 g/dL, with no alloantibodies or previous transfusion reaction. For this operation, simple transfusion toward a guideline-appropriate target is a reasonable plan to discuss. If the baseline is 10.5 g/dL, adding red cells reflexively could increase viscosity. If transfusion is still judged important because of a severe phenotype, exchange is the more appropriate discussion. The strong answer reasons from the whole case, not genotype alone.

Keep perioperative physiology steady

Plan with the patient’s haematologist, surgeon and transfusion service. Schedule the case early where possible and avoid unnecessarily long periods without oral fluids. Maintain euvolaemia: dehydration is hazardous, but indiscriminate fluid loading can also cause harm, particularly with renal or cardiac disease.

Use standard monitoring and pay close attention to temperature and oxygen saturation. Preoxygenate before induction, avoid hypotension, and use controlled ventilation to maintain oxygenation and normocapnia. Active warming, warmed fluids when appropriate and limiting unnecessary exposure help prevent hypothermia and shivering.

General anaesthesia is usual for laparoscopic surgery. Plan multimodal analgesia before induction, continue established long-acting analgesia where appropriate, and account for opioid tolerance or sensitivity. Non-steroidal anti-inflammatory drugs can reduce opioid requirements, but use them cautiously when renal impairment is present. Monitor neuromuscular blockade and ensure full reversal before extubation; residual weakness and hypoventilation promote atelectasis and hypoxaemia.

Treat postoperative desaturation as a diagnosis, not a number

Suppose the patient becomes tachypnoeic and desaturates in recovery. Assess airway, breathing and circulation. Check the oximeter signal, give oxygen for hypoxaemia, and assess respiratory effort, consciousness, analgesia and residual neuromuscular block. Consider common causes such as airway obstruction, opioid-related hypoventilation, atelectasis, aspiration and pulmonary embolism. The sickle-cell diagnosis should not distract you from these possibilities, but a presumed routine cause must not delay consideration of ACS.

ACS is suggested by new respiratory symptoms—such as chest pain, fever, cough or tachypnoea—together with a new pulmonary infiltrate on chest X-ray. A falling oxygen saturation may be an early warning. Obtain a chest X-ray and blood tests, including a full blood count; use arterial blood gas analysis or further imaging when the clinical picture requires it. Investigate infection and other causes of deterioration at the same time.

Escalate early to senior anaesthesia, haematology and critical-care teams if hypoxaemia persists, work of breathing rises or the patient deteriorates. Support oxygenation, provide effective analgesia, treat infection when suspected and use respiratory support as needed. Transfusion depends on severity and haemoglobin. Simple transfusion or exchange may be considered for moderate ACS; exchange is favoured for severe or rapidly progressive ACS, failure to respond to simple transfusion, or a high baseline haemoglobin that makes simple transfusion unsuitable. An uncomplicated painful crisis alone is not an indication for transfusion.

Protect the recovery

Postoperative care is part of the anaesthetic, not an afterthought. Monitor oxygen saturation against baseline, maintain warmth and fluid balance, and control pain well enough for the patient to breathe deeply and mobilise. Encourage lung-expansion exercises, such as incentive spirometry after moderate or major surgery, and early mobilisation. Provide chest physiotherapy if the patient cannot mobilise effectively. Prescribe venous thromboembolism prophylaxis unless contraindicated, following local policy. Choose ward, high-dependency or intensive-care observation according to disease severity, previous complications, current physiology and the operation.

An examiner may now ask how the plan changes for cardiac or neurosurgery. These are very high-risk procedures, for which preoperative exchange may be considered with the target agreed by the specialist team. They may ask about transfusion complications: alloimmunisation, delayed haemolytic reactions, hyperhaemolysis and hyperviscosity. Or they may return to the desaturating patient. Recognise ACS early, investigate and treat it alongside other causes, and involve the teams who can escalate care.

The oral answer follows the case: assess phenotype, justify the transfusion strategy, prevent avoidable triggers and respond promptly to postoperative deterioration. Rehearse that reasoning with the Final/Advanced Anesthesia Structured Oral Examination (SOE), or explore the wider anaesthesia exam practice options.